Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)

医学 传统PCI 四分位间距 心肌梗塞 血运重建 罪魁祸首 经皮冠状动脉介入治疗 内科学 心脏病学 血管成形术 外科
作者
Kevin R. Bainey,David Wood,Matthias Bossard,Gianluca Campo,Warren J. Cantor,Shahar Lavi,Mina Madan,Roxana Mehran,Natalia Pinilla‐Echeverri,Sunil V. Rao,Jaydeep Sarma,Tej Sheth,Goran Stanković,Philippe Gabríel Steg,Robert F. Storey,Jean‐François Tanguay,James L. Velianou,Robert C. Welsh,Thenmozhi Mani,John A. Cairns
出处
期刊:American Heart Journal [Elsevier]
卷期号:267: 70-80 被引量:10
标识
DOI:10.1016/j.ahj.2023.10.004
摘要

In ST-segment elevation myocardial infarction (STEMI), complete revascularization with percutaneous coronary intervention (PCI) reduces major cardiovascular events compared with culprit-lesion-only PCI. Whether age influences these results remains unknown. COMPLETE was a multinational, randomized trial evaluating a strategy of staged complete revascularization, consisting of angiography-guided PCI of all suitable nonculprit lesions, versus a strategy of culprit-lesion-only PCI. In this prespecified subgroup analysis, treatment effect according to age (≥65 years vs <65 years) was determined for the first coprimary outcome of cardiovascular (CV) death or new myocardial infarction (MI) and the second coprimary outcome of CV death, new MI, or ischemia-driven revascularization (IDR). Median follow-up was 35.8 months (interquartile range [IQR]: 27.6-44.3 months). Of 4,041 patients randomized in COMPLETE, 1,613 were aged ≥ 65 years (39.9%). Higher event rates were observed for both coprimary outcomes in patients aged ≥ 65 years comparted with those aged < 65 years (11.2% vs 7.9%, HR 1.49, 95% CI 1.22-1.83; 14.4% vs 11.8%, HR 1.28, 95% CI 1.07-1.52, respectively). Complete revascularization reduced the first coprimary outcome in patients ≥ 65 years (9.7% vs 12.5%, HR 0.77; 95% CI, 0.58-1.04) and < 65 years (6.7% vs 9.1%, HR 0.72; 95% CI, 0.54-0.96)(interaction P = .74). The second coprimary outcome was reduced in those ≥ 65 years (HR 0.56, 95% CI, 0.43-0.74) and < 65 years (HR 0.48, 95% CI, 0.37-0.61 (interaction P = .37). A sensitivity analysis was performed with consistent results demonstrated using a 75-year threshold (albeit attenuated). In patients with STEMI and multivessel CAD, complete revascularization compared with culprit-lesion-only PCI reduced major cardiovascular events regardless of patient age and could be considered as a revascularization strategy in older adults.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
leo发布了新的文献求助50
1秒前
张文静发布了新的文献求助10
2秒前
123完成签到 ,获得积分20
3秒前
优秀丹南完成签到,获得积分10
3秒前
善学以致用应助逆天子采纳,获得10
4秒前
刘威完成签到,获得积分10
4秒前
Sunny发布了新的文献求助150
5秒前
6秒前
7秒前
chenhoe1212完成签到 ,获得积分10
8秒前
赘婿应助qq采纳,获得10
9秒前
123关注了科研通微信公众号
10秒前
CodeCraft应助跳跃的一凤采纳,获得10
11秒前
11秒前
yy完成签到 ,获得积分10
12秒前
CuSO4完成签到,获得积分10
13秒前
13秒前
小二郎应助书记采纳,获得10
14秒前
14秒前
脑洞疼应助xh采纳,获得10
15秒前
16秒前
陈一昂完成签到,获得积分20
16秒前
李健的小迷弟应助张二田采纳,获得10
16秒前
Jade完成签到 ,获得积分10
17秒前
王羲之发布了新的文献求助10
17秒前
思源应助岳麓山的月亮采纳,获得10
17秒前
芋头读文献完成签到,获得积分10
18秒前
陈一昂发布了新的文献求助10
18秒前
森活鱼块完成签到,获得积分10
18秒前
21秒前
21秒前
21秒前
LJJ完成签到,获得积分10
22秒前
22秒前
歪歪yyyyc完成签到,获得积分10
23秒前
意忆完成签到,获得积分10
23秒前
xh发布了新的文献求助10
24秒前
七音秦完成签到,获得积分10
24秒前
haonanchen完成签到,获得积分10
24秒前
量子星尘发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1581
以液相層析串聯質譜法分析糖漿產品中活性雙羰基化合物 / 吳瑋元[撰] = Analysis of reactive dicarbonyl species in syrup products by LC-MS/MS / Wei-Yuan Wu 1000
Biology of the Reptilia. Volume 21. Morphology I. The Skull and Appendicular Locomotor Apparatus of Lepidosauria 600
The Scope of Slavic Aspect 600
Foregrounding Marking Shift in Sundanese Written Narrative Segments 600
Rousseau, le chemin de ronde 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5540496
求助须知:如何正确求助?哪些是违规求助? 4627046
关于积分的说明 14602145
捐赠科研通 4568063
什么是DOI,文献DOI怎么找? 2504344
邀请新用户注册赠送积分活动 1481989
关于科研通互助平台的介绍 1453623